Mersana Therapeutics Inc. (NASDAQ:MRSN) is one of the best penny stocks under $1 to buy now. Earlier in June, Mersana ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

--American Oncology Network, one of the nation’ s fastest-growing networks of community oncology practices, is pleased to announce that multiple research studies co-authored by AON physicians ...

Tempus Announces 10 Abstracts Accepted for Presentation at the 2025 American Society of Clinical Oncology Annual Meeting. Share. CHICAGO--(BUSINESS WIRE) ...

ImmunoGenesis to present IMGS-001 Phase 1a/1b Clinical Study Updates at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. PR Newswire. HOUSTON, May 30, 2025.

ASCO convened a panel of experts to update the clinical guidelines for fertility preservation in men, women, and adolescents with cancer.

The data were featured during an oral presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 30-June 3, 2025, in Chicago and online.

Complete coverage of the American Society of Clinical Oncology (ASCO) annual meeting.

Ahead of the American Society of Clinical Oncology (ASCO) 2025 annual meeting, Sanjay Goel, MD, MS, professor of medicine at Robert Wood Johnson Medical School and medical oncologist at Rutgers ...

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data presented at the annual meeting of the American Society of Clinical ...

PDS Biotech Unveils Updated Positive Data From VERSATILE-002 Trial and Additional Trials Evaluating Versamune® HPV to Treat Head and Neck Cancers at the 2025 American Society of Clinical Oncology ...

Expanding oncology training programs and investing in mentorship initiatives can support career development and increase the number of qualified oncology specialists. 74 International partnerships, ...